Hepatology 2009 Current Perspectives on Chronic Liver Disease		(Recorded East Coast Satellite Broadcast Webcast)
			0.5 AMA PRA Category 1 Credits (Expires on June 22, 2010)
	Current Perspectives on Hepatocellular Carcinoma		(Webcast)
	Presented by: Myron Tong, MD		No CME credit available

	HCC 2009 New>  Hepatocellular Carcinoma
	HCC Slide Archive
	HCC 2008 Hepatocellular Carcinoma

Preoperative prediction of poorly differentiated components in small-sized hepatocellular carcinoma for safe local ablation therapy Imai K, Beppu T, Nakayama Y, Ishiko T, Horino K, Komori H, Masuda T, Hayashi H, Okabe H, Baba Y, Watanabe M, Takamori H, Awai K, Yamashita Y, Baba H. J Surg Oncol 2009 Apr 28 (Epub ahead of print) Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL. Hepatology 2008;49:1563-1570. Hepatocellular carcinoma in patients with cryptogenic cirrhosis Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M; Italian Liver Cancer (ITALICA) Group. Clinical Gastroenterol Hepatol. 2009;7:580-5. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities Xiangji L, Weifeng T, Bin Y, Chen L, Xiaoqing J, Baihe Z, Feng S, Mengchao W. Langenbecks Arch Surg. 2009 may 7. (Epub ahead of print) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network. Am J Gastroenterol 2003;9:2060-3. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis Pinter M, Sieghart W, Graziadei I, Vogel W, Maieron A, Königsberg R, Weissmann A, Kornek G,Plank C, Peck Radosavljevic M. Oncologist 2009;14(1):70-6. Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma Thomas M, Morris J, Chadha R, Iwasaki M, Kaur H, Lin E, Kaseb A, Glover K, Davila M, and Abbruzzese J. J Clin Oncol 2009;27(6):843-850. The burden of illness associated with hepatocellular carcinoma in the United States Lang K, Danchenko N, Gondek K, et al. J Hepatol 2009;50:89-99. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B Yuen M, Tanaka Y, Fong D, et al. J Hepatol 2009;50:80-88. Novel Advancements in the management of hepatocellular carcinoma in 2008 LLovet J, Bruix J. J Hepatol 2008;48:S20-S37. Increased Risk of Hepatocellular Carcinoma Among Patients with Hepatitis C Cirrhosis and Diabetes Mellitus Veldt B, Chen W, Heathcote J, Wedemeyer H, Reichen J, Hoffmann W, de Knegt R, Zeuzem S, Manns M, Hansen B, Schalm S, and Janssen H. HEPATOLOGY 2008;47:1856-1862. Diagnosis and Treatment of Hepatocellular Carcinoma El-Serag H, Marrero J, Rudolph L, and Reddy K. Gastroenterology 2008;134:1752-1763. Sorafenib in Advanced Hepatocellular Carcinoma Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J, de Oliveira A, Santoro A, Raoul J, Former A, Schwartz M, Porta C, Zeuzem, Bolondi L, Greten T, Galle P, Seitz J, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, and Bruix J for the SHARP Investigators Study Group. N Engl J Med 2008;359:378-90. Sorafenib in Liver Cancer-Just the Beginning Roberts LR. N Engl J Med 2008;359:420-422.